AR and substance dependence: These agents inhibit not only the binding of androgens to androgen receptors but also their nuclear translocation, thereby suppressing the growth of androgen-dependent tumors, leading to the development of castration-resistant, castration-free, distant metastasis-free, and androgen-dependent tumors (Clegg et al., 2012).